Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Umstätter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Canadian Journal of Microbiology|September 24, 2019
Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteriaEric Mühlberg, Florian Umstätter, Christian Kleist, et al.
Nanomedicine (London, England)|July 16, 2021
Trends in liposomal nanocarrier strategies for the oral delivery of biologicsEric Mühlberg, Mira Burtscher, Florian Umstätter, et al.
Molecules (Basel, Switzerland)|August 21, 2019
Replacement of l-Amino Acids by d-Amino Acids in the Antimicrobial Peptide Ranalexin and Its Consequences for Antimicrobial Activity and BiodistributionCornelius Domhan, Philipp Uhl, Christian Kleist, et al.
Antibiotics (Basel, Switzerland)|December 1, 2020
Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)Philip Storck, Florian Umstätter, Sabrina Wohlfart, et al.
Angewandte Chemie (International Ed. in English)|March 20, 2020
Vancomycin Resistance Is Overcome by Conjugation of Polycationic PeptidesFlorian Umstätter, Cornelius Domhan, Tobias Hertlein, et al.
Pharmaceuticals (Basel, Switzerland)|June 4, 2020
Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant EnterococciEric Mühlberg, Florian Umstätter, Cornelius Domhan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Advanced Healthcare Materials|February 22, 2024
Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal NanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and PharmacokineticsFlorian Umstätter, Julia Werner, Leah Zerlin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam AntibioticsJulia Werner, Florian Umstätter, Manuel B Böhmann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Canadian Journal of Microbiology|September 24, 2019
Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteriaEric Mühlberg, Florian Umstätter, Christian Kleist, et al.
Nanomedicine (London, England)|July 16, 2021
Trends in liposomal nanocarrier strategies for the oral delivery of biologicsEric Mühlberg, Mira Burtscher, Florian Umstätter, et al.
Molecules (Basel, Switzerland)|August 21, 2019
Replacement of l-Amino Acids by d-Amino Acids in the Antimicrobial Peptide Ranalexin and Its Consequences for Antimicrobial Activity and BiodistributionCornelius Domhan, Philipp Uhl, Christian Kleist, et al.
Antibiotics (Basel, Switzerland)|December 1, 2020
Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)Philip Storck, Florian Umstätter, Sabrina Wohlfart, et al.
Angewandte Chemie (International Ed. in English)|March 20, 2020
Vancomycin Resistance Is Overcome by Conjugation of Polycationic PeptidesFlorian Umstätter, Cornelius Domhan, Tobias Hertlein, et al.
Pharmaceuticals (Basel, Switzerland)|June 4, 2020
Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant EnterococciEric Mühlberg, Florian Umstätter, Cornelius Domhan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Advanced Healthcare Materials|February 22, 2024
Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal NanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and PharmacokineticsFlorian Umstätter, Julia Werner, Leah Zerlin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam AntibioticsJulia Werner, Florian Umstätter, Manuel B Böhmann, et al.
Pageof 1